Show simple item record

dc.contributor.authorKoenes, Leonie
dc.date.accessioned2025-04-28T08:50:22Z
dc.date.available2025-04-28T08:50:22Z
dc.date.issued2024
dc.identifier.urihttp://hdl.handle.net/10832/4333
dc.description.abstractHeartworm disease, caused by Dirofilaria immitis, is an increasingly prevalent illness in canines that can lead to severe complications if left untreated. Transmitted by mosquitoes, it is a globally disseminated disease, particularly common in Europe, Asia, Australia, and North America. The objective of this review is to provide an overview of heartworm disease and emphasize the significance of Macrocyclic lactones in heartworm prophylaxis. Additionally, current findings on resistance, dosing strategies, and side effects are summarized. Macrocyclic lactones, which are the primary agents for heartworm prevention, are classified into two groups: avermectin and milbemycin.en_US
dc.language.isoenen_US
dc.titleLiterature review about the use of macrocyclic lactones in heartworm diseaseen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record